BRAF and colorectal neoplasm: The metabolism/mitochondria activity score was confirmed as an independent positive parameter to predict the BRAF-V600E mutation status of colorectal tumors (multi-variable model: odds ratios: 6.53 and p-value = 3.32 × 10−5, Table 3).